Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Hvidovre – page 88

1 426 clinical trials in Hvidovre, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Hvidovre at a glance
1 426
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 426 trials in Hvidovre

Open in trial search

Neoplasm

Not recruiting

Study on DF1001, Nivolumab, and Paclitaxel for Patients with Advanced Solid Tumors

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:DF1001
  • Sponsor:Dragonfly Therapeutics Inc.

Study on the Effects of Apixaban, Acetylsalicylic Acid, and Rivaroxaban on Heart Valve Thickening in Patients with Aortic Valve Replacement

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Region Hovedstaden
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Region Hovedstaden

Acute myeloid leukaemia+1

Not recruiting

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Enasidenib Mesilate
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Study on the Safety and Effectiveness of ProTrans for Treating Type 1 Diabetes in Children and Adolescents

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Protrans
  • Sponsor:Region Uppsala

Study of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:pharmaand GmbH

Ovarian cancer

Not recruiting

Study of olaparib, durvalumab and UV1 combination as maintenance treatment for patients with recurrent ovarian cancer who do not have BRCA mutations

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Nordic Society Of Gynaecological Oncology Clinical Trial Unit

Colorectal cancer

Not recruiting

Study of organ preservation using chemoradiotherapy and transanal surgery compared to standard surgery in patients with early rectal cancer (STAR-TREC trial)

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:The University Of Birmingham

Neuroblastoma

Not recruiting

Study on Bevacizumab with Temozolomide and Irinotecan for Children with Relapsed or Refractory Neuroblastoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Bevacizumab
  • Sponsor:The University Of Birmingham

Elective surgery

Not recruiting

Study on Ephedrine and Rocuronium for Faster Muscle Relaxation in Patients Aged 80 and Above Undergoing Elective Surgery

Registered drug
Countries:DenmarkDenmark
  • Participants:65+ years
  • Substances:Saline
  • Sponsor:Region Hovedstaden

Alcohol use disorder

Not recruiting

Study of Single Dose Psilocybin Treatment for Adults with Alcohol Use Disorder

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Region Hovedstaden

Osteoarthritis

Not recruiting

Study on Tranexamic Acid for Reducing Blood Loss in Osteoarthritis Patients Undergoing Total Hip Replacement

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Tranexamic Acid
  • Sponsor:Region Hovedstaden

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Hvidovre

What the registry says about research in the country

01 Infectious Disease Prevention

Research focusing on vaccine development and preventive measures against various infections, including studies on meningococcal vaccines for infants and Group B streptococcus prevention in pregnant women.

  • Meningococcal Infection Prevention
  • Streptococcal Disease Control
  • HIV Prevention Studies

Trials include evaluation of vaccine immunogenicity and safety profiles in different age groups.

02 Maternal and Women's Health

Innovative research addressing maternal mental health and pregnancy-related conditions, with studies focusing on postpartum depression prevention and maternal vaccination strategies.

  • Postpartum Depression Treatment
  • Pregnancy-Related Vaccinations
  • Caesarean Section Pain Management

Clinical investigations emphasize both maternal safety and infant outcomes.

03 Metabolic and Digestive Disorders

Comprehensive studies on inflammatory bowel diseases and metabolic conditions, including innovative treatments for obesity and diabetes management.

  • Crohn's Disease Therapies
  • Ulcerative Colitis Management
  • Weight Management Solutions

Trials evaluate both established and novel therapeutic approaches.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.